The most advanced vaccine for dengue only offers modest protection but could still help millions of people avoid the devastating effects of the disease known as “breakbone fever,” according to a large trial...
Giving children under 5 years old an extra dose of inactivated polio vaccine (IPV) helps to boost their immunity to the poliovirus and should be added to vaccination programmes in polio-endemic countries and those...
The considerable diversity of HIV worldwide represents a critical challenge for designing an effective HIV vaccine. Now, a scientific team led by Beth Israel Deaconess Medical Center (BIDMC) has shown that...
For the first time in 50 years of dengue research, the first safe, effective and affordable anti-dengue vaccine in the world could be out commercially in the country by end of next year. This was announced by Guillaume...
The Koch Institute for Integrative Cancer Research at MIT recently developed a new way to deliver vaccines for polio, influenza and measles directly to lymph nodes, which produces a stronger immune response. “The lymph...
A drug giant has achieved breakthroughs in the development of a dengue vaccine, which could be ready by the end of next year, the Straits Times reported Monday. Guillaume Leroy, head of the dengue vaccine unit of drug...
In an important step toward the creation of a vaccine against deadly coronaviruses, researchers from Purdue University have figured out how to disable a key enzyme of the SARS virus that helps it trick the immune system...
A research team from the The Scripps Research Institute (TSRI) has been awarded a grant of over $13 million from the National Institute of Allergy and Infectious Disease of the National Institutes of Health to research...
The Joint United Nations Program on HIV/AIDS (UNAIDS) called on May 18, HIV Vaccine Awareness Day, for an increase in global efforts to find an effective HIV vaccine and to accelerate progress towards ending the AIDS...
A seroprotective response to a challenge dose of hepatitis B vaccine was seen in more than 90% of study participants who received the vaccine an infant, according to recent study findings published in Pediatrics. Amy B...